3x5 Partners: Funding, Team & Investors | Startup Intros

Loading organizations...

3x5 Partners: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2022	Bonum Therapeutics	$93.0M Series A	—	Codon Capital, Digitalis Ventures, RiverVest, Roche Venture Fund, RiverVest Venture Partners, Roche, Mitchell Mutz
Aug 1, 2022	Fervo Energy	$140.0M Series C	Matt Trevithick	Breakthrough Energy Ventures, Future Ventures, Capricorn Investment Group, Congruent Ventures, Elemental Excelerator, Grantham Foundation, Helmerich & Payne, Impact Science Ventures, Chris Wright, Macquarie, Prelude Ventures
Apr 1, 2022	Kaleidoscope	$10.0M Series A	Rally Ventures, Joe Biller, CFA	Craft Ventures, CRV, Grotech Ventures, Dino Vendetti, Noam Bardin, Steven Kamali
Feb 1, 2022	Koya Medical	$26.0M Series B	Joe Biller, CFA	5AM Ventures, Arboretum Ventures, F-Prime Capital Partners, HealthQuest Capital, Telegraph Hill Partners, Asahi Kasei Ventures, Cadence Healthcare Ventures, Scientific Health Development
Dec 1, 2021	Good Therapeutics	$8.0M Series B	—	Caixa Capital, Digitalis Ventures, Faber, InterWest, Kurma Partners, Paul Walker, RiverVest, Roche Venture Fund, Sanofi Ventures, RiverVest Venture Partners, Roche
Aug 31, 2021	Claros Technologies	$5.0M Series A	Nicholas Walrod	—
May 23, 2021	Arch Oncology	$105.0M Series C	Joe Biller, CFA, Eric Pham, Joy Ghosh	Adage Capital Management, Avego Healthcare Capital, Broadfin Holdings, FMB Research, Lightchain, Point72, John McKearn, Roche
May 21, 2020	Good Therapeutics	$11.0M Other Equity	—	Codon Capital, Digitalis Ventures, RiverVest Venture Partners, Roche
May 1, 2020	Amplyx Pharmaceuticals	$53.0M Series C	Sofinnova Ventures	Abingworth, Deerfield Management, Frazier Healthcare Partners, Ed Mathers, New Enterprise Associates, RiverVest, Adage Capital Management, Arix Bioscience, BioMed Ventures, Lundbeckfond Ventures, Pappas Capital, Pfizer, RiverVest Venture Partners
Mar 25, 2019	Arch Oncology	$50.0M Series B	Rodger Riney	John McKearn, Roche
Dec 1, 2017	Allakos	$100.0M Series B	New Enterprise Associates	InterWest, Paul Walker, Novo Ventures, RiverVest, Roche Venture Fund, SR One, Alta Partners, LifeSci Venture Partners, Partner Fund Management, Redmile Group, RiverVest Venture Partners, Roche, Rock Springs Capital, Samsara BioCapital
Jun 1, 2017	Fishpeople Seafood	$12.0M Series B	Advantage Capital	Blueberry Ventures, Nicholas Walrod, Collaborative Fund, Jason Scott, Chuck Templeton
Feb 9, 2016	Amplyx Pharmaceuticals	$8.7M Series B	Anthony Arnerich	—